Arterial stiffness, wave reflections and myocardial protection: The REASON project;Protection myocardique, rigidité artérielle et ondes de réflexion: l'Étude REASON

Drugs

Volumn 63, Issue SPEC. ISS. 1, 2003, Pages 9-17

  London, Gérard M ^a  

^a Centre Hospitalier FH Manhes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; INDAPAMIDE; PERINDOPRIL;

ARTERY COMPLIANCE; ARTERY STIFFNESS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREDICTION; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 17744418525     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200363991-00002     Document Type: Conference Paper

References (42)

1. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74
2. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-6
3. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension 1999; 34: 386-7
4. Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Hypertension 1999; 34: 381-5
5. Black HR, Elliott WJ, Neaton JD, et al. Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertension 2001; 37: 12-8
6. Darne B, Girerd X, Safar M, et al. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989; 13: 392-400
7. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30: 1410-5
8. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease?. The Framingham Heart Study. Circulation 1999; 100: 354-60
9. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17: 1065-72
10. Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160: 1085-9
11. Safar ME. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 2001; 10: 257-61
12. Gasowski J, Fagard RH, Staessen JA, et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002; 20: 145-51
13. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998; 16: 761-9
14. Benetos A, Rudnichi A, Safar M, et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-4
15. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96: 308-15
16. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-72
17. Somes GW, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999; 159: 2004-9
18. O'Rourke MF. Wave travel and reflection in the arterial system. J Hypertens 1999; 17 Suppl. 5: S45-7
19. Struijker-Boudier HA, le Noble JL, Messing MW, et al. The microcirculation and hypertension. J Hypertens Suppl. 1992; 10: S147-56
20. Levy BI, Ambrosio G, Pries AR, et al. Microcirculation in hypertension: a new target for treatment? Circulation 2001; 104: 735-40
21. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70: 921-61
22. O'Rourke MF. Mechanical principles: arterial stiffness and wave reflection. Pathol Biol (Paris) 1999; 47: 623-33
23. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735-8
24. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41
25. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-5
26. Carretero OA, Oparil S. Essential hypertension: part II, treatment. Circulation 2000; 101: 446-53
27. Safar ME, van Bortel LM, Struijker-Boudier HA. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res 1997; 34: 67-81
28. Rakusan K, Cicutti N, Maurin A, et al. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Microvasc Res 2000; 59: 243-54
29. Levy BI, Duriez M, Samuel JL. Coronary microvasculature alteration in hypertensive rats: effect of treatment with a diuretic and an ACE inhibitor. Am J Hypertens 2001; 14: 7-13
30. Asmar RG, London GM, O'Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. The REASON Project coordinators and investigators. Hypertension 2001; 38: 922-6
31. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26: 485-90
32. Nichols WW, O'Rourke MF, Hartley C, et al. McDonald's blood flow in arteries: theoretic, experimental, and clinical principles. 4th ed. London: E. Arnold, 1998: 54-113, 201-222, 284-292, 347-401
33. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens 1996; 14 Suppl. 5: S147-57
34. London GM, Pannier B, Guerin AP, et al. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90: 2786-96
35. Topouchian J, Asmar R, Sayegh F, et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999; 30: 1056-64
36. Wilkinson IB, Fuchs SA, Jansen IM, et al. Reproducibility of pulse wave velocity and augmentation index measure by pulse wave analysis. J Hypertens 1998; 16: 2079-84
37. De Luca N, Safar ME. Efficacy of a very low dose perindopril 2mg/indapamide 0.625mg on cardiac hypertrophy in hypertensive patients. The REASON project [abstract]. J Hypertens 2002; 20 Suppl. 4: S164
38. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6
39. Muiesan ML, Salvetti M, Rizzoni D, et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13: 1091-5
40. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54
41. Chen C-H, Ting C-T, Lin S-J, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995; 25: 1034-41
42. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 2001; 19: 1001-6